Can a simple program help more kidney patients get transplants?
NCT ID NCT07515794
First seen Jun 27, 2026 · Last updated Jul 07, 2026 · Updated 2 times
Summary
This study follows about 793 people with chronic kidney disease who previously took part in a program designed to help them talk to doctors and family about kidney transplants. Researchers want to see if the program's effects last over time, including whether patients start transplant evaluations, find living donors, or receive a transplant. The goal is to learn how to make transplants more common and fair for everyone.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this could show that simple behavioral programs help more kidney patients get transplants sooner and more equitably.
- What could go wrong
- This is an observational follow-up, not a treatment trial. It cannot prove that the program causes better outcomes, and results may not apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 793 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Jun 2026
- Expected to finish
-
Dec 2029
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Participants previously enrolled in STEPS study will participate in this extension study (STEPS-LT).
- Ages
-
18 to 75 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: \- STEPS study participants who did not withdraw consent during the study or have not died. Exclusion Criteria: \- Not previously enrolled in STEPS study
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Chronic kidney diseases are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
The full official record for this study. This one lists no contact details, but it is the first place any would appear.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Wake Forest University Health Sciences
Winston-Salem, North Carolina, 27101, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a nurse and a neighbor help tame chronic disease?
- Which SGLT2 inhibitor wins? trial pits empagliflozin against dapagliflozin
- Does better dialysis keep parathyroid hormone in check?
- Biobank aims to unlock the mysteries of calciphylaxis
- Do kidney patients know why a fistula matters before dialysis?
- Potassium binder may let kidney patients keep Life-Saving heart drugs